Product Description: DBCO-PEG4-VA-PBD is a agent-linker conjugate for ADC by using the antitumor antibiotic, Pyrrolobenzodiazepine (PBD), linked via DBCO-PEG4-VA[1]. DBCO-PEG4-VA-PBD is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
Applications: Cancer-programmed cell death
Formula: C80H87N9O16
References: [1]Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
CAS Number: 2241644-09-5
Molecular Weight: 1430.60
Compound Purity: 96.94
Research Area: Cancer
Solubility: DMSO : 120 mg/mL (ultrasonic)
Target: Drug-Linker Conjugates for ADC